Mesothelioma Avastin Plus Pemetrexed-cisplatin Study

NCT00651456 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

448

Enrollment

OTHER

Sponsor class

Conditions

Mesothelioma

Interventions

DRUG: Standard Chemotherapy (Pemetrexed and Cisplatin)
DRUG: Standard Chemotherapy (Pemetrexed and Cisplatin) + Bevacizumab

Sponsor

Intergroupe Francophone de Cancerologie Thoracique

Collaborators

[object Object]
[object Object]